Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Effects of controlled hypotension with restrictive transfusion on intraoperative blood loss and systemic oxygen metabolism in elderly patients who underwent lumbar fusion.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Qiu X;Qiu X; Tan Z; Tan Z; Tang W; Tang W; Ye H; Ye H; Lu X; Lu X
  • المصدر:
    Trials [Trials] 2021 Jan 28; Vol. 22 (1), pp. 99. Date of Electronic Publication: 2021 Jan 28.
  • نوع النشر :
    Journal Article; Randomized Controlled Trial
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: [London] : BioMed Central, 2006-
    • الموضوع:
    • نبذة مختصرة :
      Background: The effects of restrictive fluid therapy combined with controlled hypotension in the elderly on systemic oxygen metabolism and renal function are clinical concerns. The aim of this study was to evaluate blood loss, oxygen metabolism, and renal function in different levels of controlled hypotension induced by intravenous nitroglycerin, in combination with limited infusion, in elderly patients undergoing posterior lumbar fusion.
      Methods: A total of 40 patients, aged 60-75 with ASA grade II or III, who were planned for posterior lumbar fusion were randomly allocated into two groups: experimental group [target mean arterial pressure 65 mmHg (MAP 65) or control group (MAP 75)]. Indicators for blood loss, hemodynamic, systemic oxygen metabolism, and renal function evaluation index were recorded before operation (T0), 1 h after induced hypotension (T1), 2 h after hypotension (T2), and in recovery (T3). We compared changes in these parameters between groups to evaluate the combined effects of controlled hypotension with restrictive infusion.
      Results: CI, DO 2 I, and VO 2 I were lower in both groups at T1-T3 compared with T0 (p < 0.05). DO 2 I and VO 2 I in the MAP 65 group were lower than the MAP 75 group after operation. In both groups, SCysC increased at T1, T2, and T3 (p < 0.05) compared with T0.
      Conclusions: Restrictive transfusion and control MAP at 65 mmHg can slightly change in renal function and reduce the risk of insufficient oxygen supply and importantly have no significant effect on blood loss and postoperative complications.
      Trial Registration: ChiCTR-INR-16008153 . Registered on 25 March 2016.
    • References:
      Eur Spine J. 2016 May;25(5):1601-1607. (PMID: 26787345)
      J Bone Joint Surg Br. 1983 May;65(3):255-8. (PMID: 6841391)
      Med Sci Sports Exerc. 2008 Mar;40(3):477-85. (PMID: 18379210)
      Anesth Analg. 1982 Mar;61(3):256-60. (PMID: 6802028)
      World J Orthop. 2014 Jan 18;5(1):51-6. (PMID: 24649414)
      Plant Physiol. 2009 Jul;150(3):1122-34. (PMID: 19429602)
      J Pediatr Pharmacol Ther. 2015 Jan-Feb;20(1):54-60. (PMID: 25859171)
      Curr Opin Crit Care. 2010 Aug;16(4):359-64. (PMID: 20613505)
      BMC Anesthesiol. 2014 Jul 30;14:61. (PMID: 25100922)
      J Spinal Disord Tech. 2015 Nov;28(9):E493-521. (PMID: 24901878)
      J Cardiothorac Vasc Anesth. 1993 Jun;7(3):273-8. (PMID: 8518372)
      Mil Med. 2011 Nov;176(11):1320-4. (PMID: 22165663)
      Eur J Vasc Endovasc Surg. 2009 May;37(5):538-43. (PMID: 19231249)
      J Clin Diagn Res. 2015 Apr;9(4):TC04-9. (PMID: 26023617)
      Cardiol Res Pract. 2011;2011:263585. (PMID: 21845218)
      Acta Anaesthesiol Scand. 1991 Nov;35(8):741-4. (PMID: 1763593)
      Anesth Prog. 1995;42(2):41-58. (PMID: 8934953)
      Spine J. 2014 Aug 1;14(8):1532-7. (PMID: 24331842)
      Clin Transl Oncol. 2019 Apr;21(4):451-458. (PMID: 30218305)
      J Bone Joint Surg Br. 1967 May;49(2):327-32. (PMID: 6026518)
    • Contributed Indexing:
      Keywords: Controlled hypotension; Renal function; Restrictive transfusion; Systemic oxygen metabolism
    • الرقم المعرف:
      G59M7S0WS3 (Nitroglycerin)
      S88TT14065 (Oxygen)
    • الموضوع:
      Date Created: 20210129 Date Completed: 20210208 Latest Revision: 20210208
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC7841987
    • الرقم المعرف:
      10.1186/s13063-020-05015-5
    • الرقم المعرف:
      33509270